Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain, Postoperative 4 Pancreatic Neoplasms 3 Lung Neoplasms 2 Liver Neoplasms 2 Agnosia 2 Uterine Cervical Neoplasms 1 Thoracic Neuritis 1 Stomach Neoplasms 1 Reperfusion Injury 1 Prostatic Neoplasms 1 Neoplasms 1 Leiomyoma 1 Inflammation 1 Endometrial Neoplasms 1 End Stage Liver Disease 1 Colonic Neoplasms 1 Breast Neoplasms 1 Breast Cancer Female 1 Bites and Stings 1 Biliary Tract Neoplasms 1 Adenomyosis 1 Acute Pain 1

Interventions

Docetaxel 292 Prednisone 241 enzalutamide 195 Leuprolide 185 Radiotherapy 179 Abiraterone Acetate 170 Magnetic Resonance Spectroscopy 163 bicalutamide 141 Goserelin 138 Androgen Antagonists 121 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108 Radiosurgery 108 apalutamide 93 abiraterone 83 gallium 68 PSMA-11 81 Specimen Handling 73 darolutamide 67 Surveys and Questionnaires 64 Gonadotropin-Releasing Hormone 63 Triptorelin Pamoate 58 Radiation 57 Biopsy 57 Brachytherapy 54 cabazitaxel 53 Standard of Care 51 Radiotherapy, Intensity-Modulated 51 Zoledronic Acid 50 pembrolizumab 49 luprolide acetate gel depot 49 Flutamide 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Analgesia, Patient-Controlled × Clear all

NCT01367418 2012-03-19

AIMS

Örebro University, Sweden

Phase 3 Completed

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡